Authors:
Cwynarski, K
Goulding, R
Pocock, C
Dazzi, F
Craddock, C
Kaeda, J
Olavarria, E
Kanfer, E
Apperley, J
Lawler, M
Goldman, JM
Citation: K. Cwynarski et al., Immune haemolytic anaemia following T cell-depleted allogeneic bone marrowtransplantation for chronic myeloid leukaemia: association with leukaemic relapse and treatment with donor lymphocyte infusions, BONE MAR TR, 28(6), 2001, pp. 581-586
Authors:
Millrain, M
Chandler, P
Dazzi, F
Scott, D
Simpson, E
Dyson, PJ
Citation: M. Millrain et al., Examination of HY response: T cell expansion, immunodominance, and cross-priming revealed by HY tetramer analysis, J IMMUNOL, 167(7), 2001, pp. 3756-3764
Authors:
Craddock, C
Szydlo, RM
Dazzi, F
Olavarria, E
Cwynarski, K
Yong, A
Brookes, P
de la Fuente, J
Kanfer, E
Apperley, JF
Goldman, JM
Citation: C. Craddock et al., Cytomegalovirus seropositivity adversely influences outcome after T-depleted unrelated donor transplant in patients with chronic myeloid leukaemia: the case for tailored graft-versus-host disease prophylaxis, BR J HAEM, 112(1), 2001, pp. 228-236
Authors:
Olavarria, E
Kanfer, E
Szydlo, R
Kaeda, J
Rezvani, K
Cwynarski, K
Pocock, C
Dazzi, F
Craddock, C
Apperley, JF
Cross, NCP
Goldman, JM
Citation: E. Olavarria et al., Early detection of BCR-ABL transcripts by quantitative reverse transcriptase-polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemia, BLOOD, 97(6), 2001, pp. 1560-1565
Authors:
Dazzi, F
Szydlo, RM
Cross, NCP
Craddock, C
Kaeda, J
Kanfer, E
Cwynarski, K
Olavarria, E
Yong, A
Apperley, JF
Goldman, JM
Citation: F. Dazzi et al., Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia, BLOOD, 96(8), 2000, pp. 2612-2616
Authors:
Dazzi, F
Szydlo, RM
Cross, NCP
Craddock, C
Kaeda, J
Kanfer, E
Cwynarski, K
Olavarria, E
Yong, A
Apperley, JF
Goldman, JM
Citation: F. Dazzi et al., Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia, BLOOD, 96(8), 2000, pp. 2712-2716
Authors:
Craddock, C
Szydio, RM
Klein, JP
Dazzi, F
Olavarria, E
van Rhee, F
Pocock, C
Cwynarski, K
Apperley, JF
Goldman, JM
Citation: C. Craddock et al., Estimating leukemia-free survival after allografting for chronic myeloid leukemia: a new method that takes into account patients who relapse and are restored to complete remission, BLOOD, 96(1), 2000, pp. 86-90
Authors:
Dazzi, F
Szydlo, RM
Craddock, C
Cross, NCP
Kaeda, J
Chase, A
Olavarria, E
van Rhee, F
Kanfer, E
Apperley, JF
Goldman, JM
Citation: F. Dazzi et al., Comparison of single-dose and escalating-dose regimens of donor lymphocyteinfusion for relapse after allografting for chronic myeloid leukemia, BLOOD, 95(1), 2000, pp. 67-71
Citation: F. Dazzi et al., Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplant: Where we now stand, EXP HEMATOL, 27(10), 1999, pp. 1477-1486
Authors:
Sartori, MT
Wiman, B
Vettore, S
Dazzi, F
Girolami, A
Patrassi, GM
Citation: Mt. Sartori et al., 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis, THROMB HAEM, 80(6), 1998, pp. 956-960